## **Core Concept**
Gynaecomastia refers to the enlargement of breast tissue in males, often caused by an imbalance between estrogen and androgen levels. This condition can result from various factors, including hormonal imbalances, certain medications, and underlying medical conditions. The key to understanding gynaecomastia lies in the **estrogen-androgen ratio**, where an increase in estrogen or a decrease in androgen levels can lead to breast tissue growth.

## **Why the Correct Answer is Right**
The correct answer, **spironolactone**, is a potassium-sparing diuretic that also acts as an **androgen receptor antagonist**. By blocking androgen receptors, spironolactone effectively reduces the effects of androgens, leading to an imbalance in the estrogen-androgen ratio. This imbalance favors the effects of estrogen, which can stimulate breast tissue growth, resulting in gynaecomastia. Other drugs and conditions that alter hormone levels can also cause gynaecomastia, but spironolactone's mechanism directly involves disrupting androgen activity.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because the condition or drug listed does not directly cause gynaecomastia through known mechanisms.
- **Option B:** Similarly, this option does not have a well-documented association with gynaecomastia.
- **Option D:** This option is also incorrect as it does not directly relate to the pathophysiology of gynaecomastia.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that gynaecomastia can be caused by medications that affect hormone levels or activity. **Spironolactone** is a notable example, as it is commonly used and has a well-documented association with gynaecomastia. Clinicians should be aware of this side effect, especially in long-term treatment plans.

## **Correct Answer:** . Spironolactone